Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Acquisition strengthens integrated radiology and pathology capabilities, enhancing access to advanced diagnostics and preventive healthcare
New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies
The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream
Approval is based on results from the phase 3 OASIS 4 clinical trial
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Subscribe To Our Newsletter & Stay Updated
